Chemoinformaics analysis of 2-Hexanol
Molecular Weight | 102.177 | nRot | 3 |
Heavy Atom Molecular Weight | 88.065 | nRig | 0 |
Exact Molecular Weight | 102.104 | nRing | 0 |
Solubility: LogS | -0.193 | nHRing | 0 |
Solubility: LogP | 0.84 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 21 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 7 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 20.1571 |
nHD | 1 | BPOL | 14.0449 |
QED | 0.513 |
Synth | 1.879 |
Natural Product Likeliness | 0.861 |
NR-PPAR-gamma | 0.003 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.077 |
HIA | 0.004 |
CACO-2 | -4.135 |
MDCK | 0.0000345 |
BBB | 0.983 |
PPB | 0.196501 |
VDSS | 0.945 |
FU | 0.780836 |
CYP1A2-inh | 0.4 |
CYP1A2-sub | 0.81 |
CYP2c19-inh | 0.036 |
CYP2c19-sub | 0.646 |
CYP2c9-inh | 0.012 |
CYP2c9-sub | 0.409 |
CYP2d6-inh | 0.005 |
CYP2d6-sub | 0.157 |
CYP3a4-inh | 0.007 |
CYP3a4-sub | 0.159 |
CL | 8.945 |
T12 | 0.842 |
hERG | 0.026 |
Ames | 0.01 |
ROA | 0.134 |
SkinSen | 0.321 |
Carcinogencity | 0.278 |
EI | 0.994 |
Respiratory | 0.035 |
NR-Aromatase | 0.006 |
Antiviral | No |
Prediction | 0.956165 |